In this episode, Dr. Brandon and Dr. Morgentaler talk about the long-standing belief that testosterone therapy increases the risk of prostate cancer, a fear that has influenced medical guidelines and practice for decades. 2:23 - Charles Huggins and Prostate Cancer Theory: Dr. Morgentaler discusses Charles Huggins' Nobel-winning research that suggested testosterone could fuel prostate cancer growth. 19:56 - Impact of Low Testosterone on Quality of Life: Many men with low testosterone experience significant issues with energy, mood, and s*xual health. 29:17 - The 94-Year-Old Patient's Influence: A 94-year-old patient's decision to try testosterone therapy led Dr. Morgentaler to rethink the risks traditionally associated with treatment. 33:16 - The TRAVERSE Trial's Findings: This pivotal study demonstrated no increased prostate cancer risk among men receiving testosterone therapy compared to those who did not. 39:13 - Why Women Don't Get Prostate Cancer: Despite having analogous glandular tissue, women rarely develop prostate cancer, a topic Dr. Morgentaler examines. Resources: Huggins, C. (1941). Studies on prostatic cancer: The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293-297. https://doi.org/10.1158/ajc.1941.293 Morgentaler, A., Bruning, E. O., & DeWolf, W. C. (1996). Occult prostate cancer in men with low serum testosterone levels. Journal of the American Medical Association, 275(24), 1904-1906. https://doi.org/10.1001/jama.1996.03530480058034 Glaser, R., & Dimitrakakis, C. (2004). Reduced breast cancer incidence in women treated with subcutaneous testosterone implants. Maturitas, 49(4), 333-338. https://doi.org/10.1016/j.maturitas.2004.04.011 Lincoff, A. M., Harman, S. M., Mora, S., Bhatt, D. L., Carson, C., Cejka, M., ... & TRAVERSE Investigators. (2023). Cardiovascular and other long-term outcomes with testosterone use in men. New England Journal of Medicine, 388(6), 495–505. https://doi.org/10.1056/NEJMoa2215025 #ProstateCancer #TestosteroneTherapy #MedicalBeliefs With Dr. Abraham Morgentaler and Dr. Marianne Brandon Listen to the podcast on all of your favorite platforms: Apple: https://podcasts.apple.com/ec/podcast/the-sex-doctors/id1761813985?l=en-GB Spotify: https://open.spotify.com/show/0apSFzquJXKoOGnmI6ndgT?si=e5a1e482c7ca46c7 Find us on: Instagram: https://www.instagram.com/thesexdoctors?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== Facebook: https://www.facebook.com/thesexdoctors YouTube: https://www.youtube.com/@thesexdoctorspod TikTok: https://www.tiktok.com/@thesexdoctor LinkedIn (Dr. Abraham): https://www.linkedin.com/in/abraham-morgentaler-md-81628b6 LinkedIn (Dr. Marianne): https://www.linkedin.com/in/mariannebrandon-59224513 X (Dr. Abraham): https://x.com/DrMorgentaler X (Dr. Marianne): https://x.com/drbrandon

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related